Shareprice
08 Apr 2026

Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

2026

25 March, 2026 Minutes from Annual General Meeting in FluoGuide A/S News Corporate Information General meeting Report of the AGM English Regulatory Listing Regulation IR
Copenhagen, Denmark, 25 March 2026 – FluoGuide A/S (“FluoGuide” or the “Company”) held its annual general...
18 March, 2026 FluoGuide receives FDA Fast Track Designation for FG001 in high-grade glioma News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English Regulatory MAR IR
Copenhagen, Denmark, 18 March 2026 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...
10 March, 2026 Notice of Annual General Meeting in FluoGuide A/S News Corporate Information General meeting Notice English Regulatory Listing Regulation IR
The board of directors hereby convenes the Annual General Meeting of FluoGuide A/S, company registration (CVR) no. 39 29 64 38 (the...
25 February, 2026 FluoGuide A/S publishes annual report for the fiscal year 2025 News English Regulatory Listing Regulation Report Annual IR
Copenhagen, Denmark, 25 February 2026 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby publishes...
25 February, 2026 FluoGuide A/S publishes interim report for Q4 2025 News English Regulatory Listing Regulation Report Interim Yearend IR
Copenhagen, Denmark, 25 February 2026 – Fluoguide A/S (“FluoGuide” or the “Company”) today releases its...
20 February, 2026 FDA clears FluoGuide’s IND for FG001 in High-Grade Glioma; U.S. clinical trial remains on track News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-listing English Regulatory Listing Regulation IR
Copenhagen, Denmark, 20 February 2026 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...
19 February, 2026 Invitation to FluoGuide A/S (Nasdaq: FLUO) live webcast on 25 February 2026 News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR
FluoGuide A/S will publish its Annual Report 2025 on Wednesday, 25 February 2026. Later that day, CEO Morten Albrechtsen and CFO Ole...
21 January, 2026 FluoGuide submits an IND for FG001, to initiate first U.S. registration trial News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR
Copenhagen, Denmark, 21 January 2026 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...

2025

19 December, 2025 FluoGuide updates IND submission timing for FG001 – trial initiation unaffected News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR
Copenhagen, Denmark, 19 December 2025 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...

FluoGuideCalendar & events